Genflow Biosciences plc
GENF.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £279 | £684 | £2,356 | £224 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £37 | £343 | £127 | £53 |
| Inventory | £0 | £0 | £0 | £0 |
| Other Curr. Assets | £69 | £41 | £131 | £0 |
| Total Curr. Assets | £384 | £1,068 | £2,615 | £277 |
| Property Plant & Equip (Net) | £2 | £3 | £2 | £0 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £0 | £0 | £0 | £0 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | -£0 | -£2 | £0 |
| Total NC Assets | £2 | £3 | £2 | £0 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £386 | £1,072 | £2,617 | £277 |
| Liabilities | – | – | – | – |
| Payables | £369 | £255 | £84 | £38 |
| Short-Term Debt | £0 | £0 | £0 | £0 |
| Tax Payable | £0 | £0 | £0 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £420 | -£164 | £84 | £146 |
| Total Curr. Liab. | £789 | £346 | £251 | £221 |
| LT Debt | £0 | £0 | £0 | £0 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £0 | £0 | £84 | £0 |
| Total NC Liab. | £0 | £0 | £84 | £0 |
| Other Liabilities | £0 | £0 | -£84 | £0 |
| Cap. Leases | £0 | £0 | £0 | £0 |
| Total Liabilities | £789 | £346 | £251 | £221 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £105 | £88 | £88 | £73 |
| Retained Earnings | -£5,591 | -£3,602 | -£2,144 | -£808 |
| AOCI | £253 | £49 | £61 | £14 |
| Other Equity | £4,830 | £4,191 | £4,361 | £776 |
| Total Equity | -£403 | £726 | £2,366 | £55 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £386 | £1,072 | £2,617 | £277 |
| Net Debt | -£279 | -£684 | -£2,356 | -£224 |